Pancreas
POST Transplant
After discharge from the hospital, activity will be limited for six to eight weeks. Mild exercise, such as walking, is encouraged but driving and strenuous exercises are prohibited. The patient must keep a daily record of temperature, intake/output, and doses and times medication is taken. Patients usually return to work within two to three months.
Infection and rejection are the main risks associated with transplants. Each transplant patient is prescribed immunosuppressive or "anti-rejection" medications. These medications prevent the body's immune system from rejecting the new transplant, known as a "rejection episode." To maximize their effectiveness, immunosuppressive medications must be taken daily throughout the patient's life. For a period of time after the transplant, patients will require routine blood tests to determine if the medication needs adjustments to prevent rejection episodes. Therefore, post-transplant patients are required to have regular follow-up visits during the first two years.
Because post-transplant medications are designed to suppress the immune system to reduce the risk of rejection, they also increase the likelihood of infection. Immediately after discharge, it is imperative that patients avoid situations which would put them at risk for infection. This includes large crowds and contact with unhealthy individuals.
Immunosuppressive medications are vital for transplant success. However, a lifetime prescription can be financially challenging. Private insurance, Medicare, and Medicaid often cover a percentage of these costs. Our financial counselors can assist the patient with information and planning.
Our medical specialists at the Texas Transplant Institute always remain available to answer any questions and provide assistance following transplantation.